![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » SANKYO TO MANUFACTURE, DISTRIBUTE OLMETIC ANTIHYPERTENSIVE DRUG IN CHINA
SANKYO TO MANUFACTURE, DISTRIBUTE OLMETIC ANTIHYPERTENSIVE DRUG IN CHINA
August 7, 2006
Shanghai Sankyo Pharmaceuticals Co., Ltd., the Chinese subsidiary of Sankyo Co., Ltd. of the Daiichi Sankyo Company, will start selling Olmetec -- generic name: olmesartan medoxomil -- an antihypertensive agent in July. Sankyo acquired manufacturing approval for the drug in April 2006.
JCN Network (http://www.japancorp.net/Article.Asp?Art_ID=12981)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct